pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
PPP-001
(cannabidiol + dronabinol)
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathet…
Tetra Bio-Pharma Inc
0
catalysts
Phase 1
PQ-203
Triple-Negative Breast Cancer (TNBC)
ProteinQure Inc
0
catalysts
Phase 1
PRGA-05
Amyotrophic Lateral Sclerosis
PRG S&Tech Inc
0
catalysts
Phase 1
← prev
page 17 of 26
next →
131
Pain
89
Neurology
1
PRGN-3006
Myelodysplastic Syndrome (Preleukemia)
$PGEN
PRECIGEN, INC.
0
catalysts
Phase 1
PRT-12396
Myelofibrosis
$PRLD
Prelude Therapeutics Inc
0
catalysts
Phase 1
PRX-012
Alzheimer's Disease
Prothena Corp Plc
0
catalysts
Phase 1
PRX-019
Neurodegenerative Diseases
Bristol-Myers Squibb Co
0
catalysts
Phase 1
PSP-001
Norovirus Infections
Prosit Sole Biotechnology (Beijing) Co Ltd
0
catalysts
Phase 1
PTH-0300
Atopic Dermatitis (Atopic Eczema)
Protheragen Inc
0
catalysts
Phase 1
PYC-003
Polycystic Kidney Disease
PYC Therapeutics Ltd
0
catalysts
Phase 1
Peptide to Inhibit CD200 for Oncology
Recurrent Glioblastoma Multiforme (GBM)
OX2 Therapeutics Inc
0
catalysts
Phase 1
Photobac
Recurrent Glioblastoma Multiforme (GBM)
Photolitec LLC
0
catalysts
Phase 1
QN-01
Smoking Cessation
Qnovia Inc
0
catalysts
Phase 1
QN-302
Metastatic Colorectal Cancer
$AIXC
AIxCrypto Holdings, Inc.
0
catalysts
Phase 1
QTX-3034
Colorectal Cancer
Quanta Therapeutics Inc
0
catalysts
Phase 1
QTX-3544
Solid Tumor
Quanta Therapeutics Inc
0
catalysts
Phase 1
QX-027N
Chronic Obstructive Pulmonary Disease (COPD)
Windward Bio AG
0
catalysts
Phase 1
QXL-138AM
Gastrointestinal Tract Cancer
Nammi Therapeutics Inc
0
catalysts
Phase 1
R-2487
Rheumatoid Arthritis
Rise Therapeutics LLC
0
catalysts
Phase 1
R-3750
Ulcerative Colitis
Rise Therapeutics LLC
0
catalysts
Phase 1
R-5780
Basal Cell Carcinoma (Basal Cell Epithelioma)
Rise Therapeutics LLC
0
catalysts
Phase 1
RAB-001d
Osteoarthritis
Zhongshan RabPharma Biopharmaceutical Co Ltd
0
catalysts
Phase 1
RBM-001
Coronavirus Disease 2019 (COVID-19)
Rock Biomedical Inc
0
catalysts
Phase 1
RCI-001
Keratoconjunctivitis Sicca (Dry Eye)
Rudacure Co Ltd
0
catalysts
Phase 1
RCT-1100
Primary Ciliary Dyskinesia
Recode Therapeutics Inc
0
catalysts
Phase 1
REC-4539
Gastric Cancer
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0
catalysts
Phase 1
RG-6538
Refractory Multiple Myeloma
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
RGDCRAdcox-2F
Pancreatic Cancer
University of Minnesota
0
catalysts
